Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Key DH Technologies is a private Canadian company operating a group of businesses focused on hydrogen and deuterium technologies rather than a pure-play biotech or pharmaceutical model. Its subsidiaries include Hydrogen Optimized, which develops and commercializes RuggedCell water electrolysis systems for large-scale green hydrogen production; Isowater, which supplies deuterium oxide to life sciences, high technology, and environmental science customers; and deutraMed, which develops specialized deuterium-containing products and research services for pharmaceutical and related applications. The company positions these units as a vertically integrated hydrogen and deuterium value chain. While it has some exposure to life science end markets through Isowater and deutraMed, the parent company is best characterized as an industrial technology and specialty materials company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Key DH Technologies.